ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved B...(--- Cash flows from operating activit...)

Date:11/5/2009

--- Cash flows from operating activities: Net loss ($2,189,000) ($2,679,000) Adjustments to reconcile net loss to net cash used in operating activities: Depreciation and amortization 111,000 120,000 Stock based compensation expense 162,000 123,000 Loss on impairment of equipment 26,000 -- Accretion of discount on short-term investments (1,000) (76,000) Net change in operating assets and liabilities: Accounts receivable, net (228,000) 1,800,000 Inventories (57,000) (856,000) Prepaid expenses and other current assets 259,000 1,000 Other assets 2,000 6,000 Accounts payable (214,000) (1,555,000) Accrued payroll and related expenses (209,000) (149,000) Deferred revenue (154,000) (240,000) Other current liabilities 237,000 569,000 ----------- ----------- Net cash used in operating activities (2,255,000) (2,936,000) ----------- ----------- Cash flows from investing activities: Capital expenditures (256,000) (105,000) Purchase of investments (1,499,000) (3,982,000) Maturities of investments 99,000 9,000,000 ----------- ----------- Net cash (used in) provided by investing activities (1,656,000) 4,913,000
'/>"/>

SOURCE ThermoGenesis Corp. Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8
Related biology technology :

1. Thermogenesis Corp. to Announce First Quarter Fiscal 2010 Results on November 5, 2009
2. ThermoGenesis Receives Notice Related to Nasdaq Minimum Closing Bid Price Rule
3. ThermoGenesis Reports Fourth Quarter and Fiscal 2009 Results
4. ThermoGenesis Announces Expanded Collaboration With Celling Technologies
5. ThermoGenesis Provides Update on Fiscal 2009 Results
6. ThermoGenesis Announces Abstracts to Be Presented at Upcoming Stem Cell Therapy Conference
7. ThermoGenesis Says FDA Concurs with Plan for Previously Announced AXP(TM) Bagset Recall
8. ThermoGenesis Corp. to Announce Second Quarter Fiscal 2009 Results on February 4, 2009
9. ThermoGenesis Presentation at Rodman & Renshaw Conference
10. ThermoGenesis Corp. to Announce First Quarter Fiscal 2009 Results on November 6, 2008
11. ThermoGenesis Announces Distribution Agreement for Bone Marrow Stem Cell Device